PMID: 6412581Jan 1, 1983Paper

Childhood non-Hodgkin's lymphoma: prognostic relevance of clinical stages and histologic subgroups

The American Journal of Pediatric Hematology/oncology
M GaspariniF Fossati-Bellani

Abstract

Seventy-nine consecutive children with non-Hodgkin's lymphoma were treated with a uniform intensive radiotherapy-chemotherapy program including high-dose MTX and CNS prophylaxis. Burkitt-type NHL was diagnosed in 44% and convoluted cell-type NHL in 33%. Complete remission rate was 97.5%. Forty-eight of 79 children (61%) remain progression-free after 18-78 months of follow-up. Patients belonging to the Burkitt type subgroup showed a peculiar clinical behavior as well as a significantly shorter survival than the other NHL patients (3-year overall survival rates of 50% vs. 72%, respectively). Clinical stages were related to the progression-free survival. It is concluded that treatment should be tailored according to the histology (Burkitt-type NHL vs. other histologic types) and the clinical stage.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

La Pediatria medica e chirurgica : Medical and surgical pediatrics
R ColellaA Ceci
International Journal of Radiation Oncology, Biology, Physics
L R MandellZ Fuks
Folia haematologica : internationales Magazin für klinische und morphologische Blutforschung
F ZintlH Schickedanz
© 2021 Meta ULC. All rights reserved